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patients with hepatic metastases has not been discussed
extensively because of a general understanding that
involvement of other organs is a contraindication to
surgery.1
Of the 351 patients in the Metastatic Lung Tumor
Study Group of Japan (MLTSGJ) who underwent pul-
monary resection for metastatic tumor from colorectal
cancer, 47 patients underwent hepatectomy for metasta-
tic tumors. We reviewed the characteristics of these 47
patients in an attempt to elucidate the effectiveness of
surgical treatment in this population.
Patients and methods 
A total of 351 patients from 11 hospitals in the Greater
Tokyo Metropolitan Area who underwent thoracotomy for
pulmonary metastases resulting from colorectal cancer were
registered in the MLTSGJ between June 1988 and June 1996.
Of these patients, 47 underwent curative pulmonary and
hepatic resection for metastatic tumors. These patients’ char-
acteristics are shown in Table I. Twenty-one patients had a
solitary pulmonary metastasis. The average number of
metastatic pulmonary tumors was 2.5. Of the 26 patients with
S urgical treatment for pulmonary metastases fromcolorectal cancer has been discussed since
Thomford, Woolner, and Clagett1 first reported the cri-
teria for the resection of metastatic lung tumors in 1965.
The utility of surgery in the treatment of patients with
pulmonary metastases from colorectal cancer is gener-
ally accepted, despite the fact that no prospective study
demonstrated its efficacy. In practice, many patients
survive more than 5 years after resection of their pul-
monary metastases. The effectiveness of the resection
of pulmonary metastases from colorectal cancer in
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multiple pulmonary metastases, 9 had bilateral metastases.
Bilateral thoracotomies were performed simultaneously in 7
of these patients. Thirty patients had a solitary hepatic metas-
tasis. The average number of hepatic metastases was 1.6.
Pulmonary surgery included wedge resection (n = 18), seg-
mentectomy (n = 14), and lobectomy (n = 15). Hepatic
surgery included partial resection or enucleation (n = 15),
subsegmentectomy or segmentectomy (n = 12), bisegmentec-
tomy (n = 2), and lobectomy (n = 16). The type of hepatic
operation was unknown in 2 patients.
Timing and sequence of pulmonary and hepatic metastases
in relation to colorectal cancer resection are shown in Fig 1.
In 25 patients, hepatic metastases were resected before the
pulmonary metastases were detected. The mean interval
between the 2 resections was 23.8 months. No patient in this
subset had a recurrent hepatic tumor or evidence of residual
hepatic tumor when the pulmonary metastases were discov-
ered. Of the 21 patients with both pulmonary and hepatic
metastases detected simultaneously, 13 underwent hepatecto-
my before thoracotomy. The interval between operations
ranged from 1 to 7 months (mean 2.6 months). Six of the 21
patients underwent hepatectomy and thoracotomy at the same
time. In 2 patients, thoracotomy was followed by hepatecto-
my. In 1 patient the pulmonary metastases were detected 9
months before the hepatic metastasis.
Vital status was available in the respective databases. For 21
patients alive when their medical records were retrieved, the
interviews were performed at the outpatient offices of the
respective hospitals to update vital status. Five patients were
lost to follow-up at this time. Follow-up periods of these
patients after last resections were 4, 11, 23, 28, and 35 months. 
In the analysis of survival, 2 types of time 0 were used.
One type of the time 0 was set to be the time at which last
resection of metastases was undertaken. This is the time at
which all the patients had both hepatic and pulmonary
metastases resected. Another type of the time 0 was set to be
the time at which initial resection of metastases was under-
taken. This is the time at which 3 patients underwent pul-
monary resection and the other patients underwent hepatec-
tomy or both hepatectomy and pulmonary resection for their
initial metastasectomy.
As this study was multi-institutional, pathologic diagnoses
were made by the pathologists belonging to the respective
institutions. When the specimens of pulmonary metastatic
lesions required pathologic analysis to eliminate second pri-
mary tumors, they were necessarily compared with the spec-
Table I. Characteristics of 47 patients undergoing
resections of both hepatic and pulmonary metastases
No. of patients
Sex
Male 30
Female 17
Age
‡ 60 y 27
<60 y 19
Unknown 1
Average 59
Range 40-82
No. of pulmonary metastases
Solitary 21
2-3 17
4-5 5
‡ 6 4
Maximum size of pulmonary metastases
<2.0 cm 19
2.0-2.9 cm 11
3.0-4.9 cm 12
‡ 5.0 3
Unknown 2
No. of hepatic metastases
Solitary 30
2 11
3 2
4 4
Mode of pulmonary resection
Wedge resection 18
Segmentectomy 14
Lobectomy 15
Location of primary cancer
Colon 26
Ascending 4
Sigmoid 22
Rectum 17
Unknown 4
Interval between primary and pulmonary metastases
Synchronous 8
<1 y 6
1≤, <2 y 13
2≤, <3 y 4
3≤, <4 y 10
4 y≤ 6
Combination therapy for hepatic metastases
Done 27
No 13
Unknown 7
Fig 1. Timing and sequence of pulmonary metastases, hepatic
metastases, and primary colorectal cancer. C, Colorectal can-
cer; L, hepatic metastases; P, pulmonary metastases.
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imens of primary colorectal tumors. When they had the same
pathologic features as those of the primary lesions, they were
diagnosed as pulmonary metastases.
Statistical analysis. The survival from the initial or the last
metastasectomy was calculated by means of the Kaplan-
Meier method.2 The significance of each prognostic factor
was determined by means of the log-rank test.
For the identification of prognostic factors, multivariable
analyses were done by the Cox semiparametric proportional
hazards regression. The following variables were entered into
the multivariable analyses: age, sex, site of colorectal prima-
ry tumor (colon or rectum), date of colorectal resection,
sequence of metastases, number of hepatic metastases, num-
ber of pulmonary metastases, date of pulmonary resection,
date of hepatic resection, follow-up date, and vital status. A P
value < .05 was considered prognostic.
Results
The cumulative survival from the last metastasecto-
my was calculated for the 47 patients who underwent
resection of pulmonary and hepatic metastases and the
304 patients who underwent resection of only pul-
monary metastases (Fig 2). The patients who under-
went pulmonary and hepatic resection had a 3-year sur-
vival of 36% ± 8%, a 5-year survival of 31% ± 8%, and
an 8-year survival of 23% ± 9%. The longest survival
was 98 months. This patient was alive without recur-
rence. The patients who underwent pulmonary resec-
tion alone had a 3-year survival of 56% ± 3%, a 5-year
survival of 40% ± 3%, and an 8-year survival of 28% ±
3%. No significant difference was noted in survival
between these 2 groups at confidence intervals of 95%
(P = .23).
The cumulative survivals after the last metastasecto-
my and after the initial metastasectomy were calculat-
ed for the 21 patients in whom the hepatic and pul-
monary metastases were detected simultaneously and
the 25 patients in whom the hepatic metastases were
detected before the pulmonary metastases (Figs 3 and
4). There was no significant difference in survival after
the last metastasectomy between these 2 groups (P =
.97). On the other hand, the cumulative survival at 5
years after the initial metastasectomy was 22% ± 12%
in the patients with the hepatic and pulmonary metas-
tases simultaneously and 50% ± 11% in the patients in
whom the hepatic metastases were detected before the
pulmonary metastases. There was a significant differ-
ence in survival after the initial metastasectomy be-
tween these 2 groups (P = .009).
The cumulative survival from the last metastasecto-
my was calculated for the 21 patients with a solitary
pulmonary metastasis and the 26 patients with multiple
pulmonary metastases (Fig 5). The patients with a soli-
tary pulmonary metastasis had a 3-year survival of 48%
± 12%, a 5-year survival of 40% ± 12%, and an 8-year
survival of 40% ± 12%. The patients with multiple pul-
monary metastases had a 3-year survival of 30% ±
12%, a 5-year survival of 22% ± 11%, and an 8-year
survival of 0%. A significant difference in cumulative
survival was seen between these 2 groups (P = .04).
In the 21 patients with a solitary pulmonary metasta-
sis, a wedge resection (n = 7), segmentectomy (n = 7),
or lobectomy (n = 7) was performed. In the 26 patients
with multiple pulmonary metastases, a wedge resection
(n = 11), segmentectomy (n = 7), or lobectomy (n = 8)
was performed. The 5-year survival of the 32 patients
who underwent wedge resection or segmentectomy
Fig 2. Kaplan-Meier survival analysis: Months after the last resection of metastases of the patients with liver
metastases and the patients without liver metastases. The P value of overall log-rank test is .23.
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was worse than that of the 15 patients who underwent
lobectomy (22% vs 44%, respectively). However, there
was no significant difference in the survivals between
these 2 groups (P = .40). Although the number of
hepatic metastases did not affect the cumulative sur-
vival after thoracotomy, there were no 8-year survivors
among the patients with multiple hepatic metastases.
Multivariable analysis shows that the only prognostic
factor after the last metastasectomy was the number of
pulmonary metastases (P = .045, Table II). On the other
hand, prognostic factors after the initial metastasecto-
my were revealed to be the number of pulmonary
metastases (P = .011 ) and the timing of the detection
of hepatic and pulmonary metastases (P = .002, Table
III).
Of the 47 patients who underwent pulmonary and
hepatic resection, 10 survived more than 3 years after
the last metastasectomy. There were 2 deaths due to
recurrences in this group, 1 at 57 months and 1 at 76
months. The remaining 8 patients were alive at the time
of this study, 41 to 99 months after resection. Two of
these patients had recurrent tumors. In 7 of these
Fig 3. Kaplan-Meier survival analysis: Months after the last resection of metastases of the patients with simulta-
neously detected hepatic and pulmonary metastases and the patients who underwent hepatectomy before the
detection of pulmonary metastases. The P value of the overall log-rank test is .97.
Fig 4. Kaplan-Meier survival analysis: Months after the initial resection of metastases of the patients with simul-
taneously detected hepatic and pulmonary metastases and the patients who underwent hepatectomy before the
detection of pulmonary metastases. The P value of the overall log-rank test is .009.
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patients, the pulmonary metastasis was solitary. In 6,
the hepatic metastasis was solitary. In 5, both metas-
tases were solitary. In 1 patient, the primary colorectal
lesion and the pulmonary metastases were detected at
the same time. In the other 9 patients, the pulmonary
metastases were detected 15 to 44 months after the
treatment of the primary colorectal tumor. The intervals
were greater than 2 years in 6 patients.
Discussion
Goldberg and associates3 have reported that among
548 patients with recurrent colorectal cancer, 222 (41%)
underwent resection, 28 (5.1%) underwent hepatecto-
my, and 20 (3.0%) underwent thoracotomy. Yamamoto
and colleagues4 have reported that of 974 patients who
underwent resection of a primary colorectal cancer, 47
(4.8%) had a hepatic metastasis develop. Among them,
16 (2.9%) underwent reoperation, but only 6 (0.6%) of
the reoperations were curative. Of the 35 (3.6%)
patients who had pulmonary metastases, only 6 (0.6%)
underwent a curative reoperation. The patients enrolled
in this study comprised 13% of the 351 cases in the
MLTSGJ in which pulmonary metastases from colorec-
tal cancer were resected. Thus these cases are not rare.
It is therefore important to determine the criteria for
resection of both pulmonary and hepatic metastases.
Fig 5. Kaplan-Meier survival analysis: Months after the last resection of metastases of the patients with solitary
pulmonary metastasis and the patients with multiple pulmonary metastases. The P value of the overall log-rank
test is .04.
Table II. Relationship of individual variables to death
after the last metastasectomy (Cox proportional hazards
method)
Variable/responses P value Hazard ratio 95% CL
Sex .6 1.276 .511-3.186
Age (60≤, 60> y) .3 .619 .263-1.458
Location of primary cancer .4 .682 .268-1.738
(colon/rectum)
Timing of hepatectomy and .7 .868 .376-2.001
pulmonary resection 
(synchronous/metachronous)
No. of pulmonary metastases .04 2.410 1.020-5.696
(solitary/multiple)
No. of liver metastases .9 .965 .398-2.337
(solitary/multiple)
CL, Confidence limit.
Table III. Relationship of individual variables to
death after the resection of hepatic metastases (Cox
proportional hazards method)
Variable/responses P value Hazard ratio 95% CL
Sex .8 1.103 .446-2.726
Age (60≤, 60> y) .6 .803 .331-1.947
Location of primary cancer .4 .677 .253-1.807
(colon/rectum)
Timing of hepatectomy and .002 .205 .075-.563
pulmonary resection 
(synchronous/metachronous)
No. of pulmonary metastases .01 3.640 1.353-9.794
(solitary/multiple)
No. of liver metastases .8 .882 .362-2.146
(solitary/multiple)
CL, Confidence limit.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 118, Number 6
Kobayashi, Kawamura, Ishihara   1095
In approximately half of the cases, the pulmonary
and hepatic metastases were detected at the same time.
In the other half, detection of the hepatic metastases
preceded detection of the pulmonary metastases. In
only 1 case, detection of the pulmonary metastasis pre-
ceded that of the hepatic metastases. Although this may
be due partly to the fact that the patients in this study
were registered mainly by thoracic surgeons, we can
assume that resectable hepatic metastases appear
before or at the time of detection of pulmonary metas-
tases in most cases. Therefore the cases in which the
detection of the hepatic metastases preceded or con-
curred with the detection of the pulmonary metastases
are discussed.
The 5-year survivals after thoracotomy for pulmonary
metastases from colorectal cancer have been reported to
range from 22% to 42%.5-8 Our data for the 47 patients
with both pulmonary and hepatic metastases were also
within this range. This means that surgical treatment in
patients with both pulmonary and hepatic metastases
may be appropriate. Extrahepatic disease has been
reported to be a poor prognostic factor for the resection
of hepatic metastases from colorectal cancer. In this
study, the 5-year survival after metastasectomy in the
synchronous group was 22%. This is in contrast to the
5-year survival of 0% to 13% reported for other extra-
hepatic disease.9-11 Moreover, the 5-year survivals after
hepatic resection of colorectal metastases have been
reported to range from 24% to 41%.9-15 These data sug-
gest that synchronous pulmonary metastases with
hepatic metastases may be different from other extra-
hepatic diseases and should not be thought of as a poor
prognostic factor for hepatectomy.
On the other hand, the 5-year survival of the syn-
chronous group after initial metastasectomy was also
significantly poorer than that of the metachronous
group. However, in the cumulative survival from the
last metastasectomy, there was no significant differ-
ence between these 2 groups, because pulmonary
metastases developed 23.8 months after hepatectomy
in the metachronous group. Multivariable analysis also
shows that the prognostic factor after the last metasta-
sectomy was only the number of pulmonary metas-
tases, although the number of pulmonary metastases
and timing of the detection of hepatic and pulmonary
metastases were prognostic factors after the initial
metastasectomy. This means that the prognosis after
the last metastasectomy, that is, after pulmonary resec-
tion of colorectal metastases, is independent of the
timing of metastases. Robinson and coworkers16
reported a similar conclusion that if the date of last
resection is chosen for the calculation of survival, the
timing of metastases is no longer a factor that influ-
ences survival.
Only the number of pulmonary metastases affected
the survival after the last metastasectomy in patients
with both pulmonary and hepatic metastases. Okumura
and associates5 reported that the 5-year survival after
thoracotomy in 22 patients with hepatic metastases and
a solitary pulmonary metastasis was 43.7%. In our
study, the 5-year survival among patients with a soli-
tary pulmonary metastasis was 40%. Such individuals
are good candidates for surgical treatment. The number
of liver metastases was not correlated with survival
after thoracotomy. However, most of the patients who
survived more than 3 years had 1 or 2 hepatic metas-
tases. Therefore surgery may be most effective in
patients with few hepatic metastases. More data are
needed to establish this pattern as valid.
Among the 21 patients with concurrent pulmonary
and hepatic metastases, 6 underwent simultaneous pul-
monary and hepatic resection. The operative procedures
included lobectomies for pulmonary and hepatic metas-
tases in 1 patient and lobectomy and partial resection
for bilateral pulmonary metastases and segmentectomy
for a hepatic metastasis in 1 patient. Segmentectomy for
pulmonary metastases and partial resection for hepatic
metastases was performed in 4 patients. In another 8
patients, the interval between the 2 resections was less
than 2 months. When thinking of resection for concur-
rent pulmonary and hepatic metastases, one must con-
sider the invasiveness of the surgical procedure. After
concurrent resection or resection within 2 months, no
operative death or deaths within 6 months occurred.
This indicates that it is safe to perform these procedures
concurrently or at close intervals. 
In conclusion, resection of pulmonary metastases
concurrent with or after resection of hepatic metastases
from colorectal cancer may be appropriate. Patients
with a solitary pulmonary metastasis and few hepatic
metastases are good candidates for this operation.
Long-term survival can be expected in these patients.
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The following institutions participated in this study: Keio
University, Cancer Institute Hospital, Chiba University,
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Center, National Defense Medical College, Saitama Medical
School, Tokyo Medical University, Tokyo Metropolitan
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